Integra Lifesciences Holdings Corp. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Integra Lifesciences Holdings Corp. filed no open-market sales and 1 open-market purchase worth $102,150, on Form 4 with the SEC. The latest: Graves Jeffrey A, Director, bought 9,000 shares at $11.35 on 5 November 2025, filed 6 November 2025.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 5 November 2025 | Graves Jeffrey A | Director | Purchase | 9,000 | $11.35 | $102,150 | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Integra Lifesciences Holdings Corp.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.